DHR vs NBIS: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Nebius Group N.V. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-08-06.
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
VS
Nebius Group N.V. · Technology
$218.99
+11.9% upside to fair value
Med Conviction
Grade C+
QuantHub Verdict
NBIS has more upside to fair value
(+11.9%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
NBIS |
| Current Price |
$195.98 |
$218.99 |
| Fair Value Estimate |
$211.54 |
$245.00 |
| Upside to Fair Value |
+7.9%
|
+11.9%
|
| Market Cap |
$138.7B |
$52.6B |
| Forward P/E |
37.8x
|
—
|
| EV / EBITDA |
22.8x
|
—
|
| Price / Sales |
5.6x
|
59.9x
|
| Price / FCF |
26.2x
|
—
|
| Revenue Growth YoY |
+3.7%
|
+684.0%
|
| Gross Margin |
60.7%
|
48.0%
|
| Operating Margin |
21.0%
|
-68.8%
|
| Return on Equity |
7.1%
|
—
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.81%
|
-4.7%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
Nebius Group is a fast-scaling neocloud GPU infrastructure provider spun out of Yandex's international assets, positioned at the center of the AI compute buildout with a validated capital relationship to Nvidia, which holds a 9.3% stake following a $2 billion investment. Revenue grew 684% year over year in Q1 2026 to $399 million, core AI cloud ARR reached $1.92 billion, and the company has locke…
Accumulation Zones
| Metric |
DHR |
NBIS |
| Zone Low |
$158.66 |
$184.00 |
| Zone High |
$179.81 |
$208.00 |
| In Buy Zone? |
No
|
No
|